For most of June, Nvidia (NASDAQ:NVDA) continued to stay in highflier mode. Even after the Nvidia stock split at the start of month, shares in the AI chip leader kept on hitting new split-adjusted highs. More recently, however, sentiment for this “Mag 7″ powerhouse has made a hard shift, from fully bullish to leaning toward
Low-priced stocks to buy with the potential to double within the next year or so have inherent appeal for investors. Individual shares are affordable making it relatively easy to establish a stake. In this case, I’ve chosen the arbitrary price level of $20. All of the shares discussed in this article are priced between $20
The financial services sector in 2024 is poised for growth, driven by robust economic fundamentals and technological advancements. As one of the largest contributors to the U.S. economy, this sector generates significant revenue and employment. Key trends include a resurgence in traditional banking, boosted by rising interest rates and economic recovery, and a notable expansion
The Buffett Indicator signals a significantly overvalued U.S. Stock Market and has drawn much attention to overvalued stocks to watch. With market cap over GDP at 192.6%, analysts expect returns to be only 0.6% a year including dividends from this level of overvaluation. Below, you’ll learn about three particular stocks that are overvalued but should
Does it make sense to invest in COVID-19 vaccine stocks in 2024? It should make sense, at least in theory, since U.S. health regulators effectively gave Novavax (NASDAQ:NVAX) the green light to target a specific Covid-19 variant. Yet, it’s too late to buy Novavax stock with confidence as meme-stock madness sent the share price to
Tesla (NASDAQ:TSLA) is still in the red for 2024, but don’t think now’s the time to scoop up Tesla stock, ahead of a possible further recovery during the back half 2024. The current investor excitement about the EV maker’s shares may not last. Demand and profitability issues persist. These factors may become a key focus
Data analytics firm Snowflake (NYSE:SNOW) is on a long slide lower. Although it impressively beat analyst expectations by a wide margin, guidance indicated a coming slowdown and profits are still nowhere in sight. As a result, the market is selling off Snowflake stock. Shares are down 35% year-to-date but 46% below its February high. A
Although labeled as the peace summit, an international call for an end to Russia’s invasion of Ukraine effectively did little more than harden ideological lines. While a great many support a roadmap to peace that encompasses Ukraine’s territorial integrity, key players – namely Russia and China, along with a few others – believe differently. What
While the economy may have bounced back on paper from the COVID-19 disaster, it’s increasingly looking like we’re headed toward a K-shaped recovery. Per Investopedia, this phenomenon refers to a recovery following a recession (or in this case an acute emergency) where “only certain sectors, industries, or areas of the economy recover.” However, this dynamic
After a couple of rough years during which the sector underwent extensive restructuring, smart investors are once again paying attention to metaverse stocks. Due to higher spending and focus on AI, investors tend to ignore the metaverse, but the market is too substantial to ignore, expected to be worth about $116.74 billion in 2024 and
When does a growth stock become one of the top growth stocks to avoid? It sounds like the beginning of a riddle or a bad joke, but the answer is obvious – it’s when the stock is deceptive and tricks you into believing that it can be a good buy. You look at the Portfolio
Don’t be fooled by the return of meme stocks. It’s curtains for AMC Entertainment (NYSE:AMC) stock. In mid-May, AMC jumped 135% higher in less than a week as investor interest in meme stocks was rekindled. However, just as quickly as AMC’s share price rose it fell again. Once again, investors who took the bait got
With the progression of modern medicine, and the continuous discoveries in the realm of gene editing, investing early in the technology could be a game changer for long-term returns if selecting the best gene editing stocks to buy. That’s because unlike more standard therapeutics such as antibiotics, antivirals and vaccines gene editing is a permanent
We are currently in an AI bull run. Stocks like Nvidia (NASDAQ:NVDA) are up over 100% year-to-date. Companies like Apple (NASDAQ:AAPL), Microsoft (NASDAQ:MSFT), and Google (NASDAQ:GOOG, NASDAQ:GOOGL) are announcing new AI-enabled services. This truly historic event opens up new growth potential for investors looking for AI stocks. Every day, new growth and value stocks are
In February, “longtime investor” Sonny Kalsi told Barron’s that the commercial real estate sector would make a comeback in 2025. The publication noted that Kalsi, who co-manages an investment division of Canadian insurer Sun Life called BGO, handles about $80 billion of commercial real estate investments. Although the bottom 25% of office properties are dead
Chinese stocks are in a rut. So says a recent article from Barron’s. Barron’s contributor Reshma Kapadia wrote on June 26: “After staging a recovery in the first five months of the year, they have again lost steam as investors look to authorities to do more to revive the economy, heal the property market, and boost
The Women’s National Basketball Association (WNBA) has been steadily gaining popularity since 2021. But this year, the league has seen an even stronger-than-expected surge in popularity. League superstars like Caitlin Clark and Angel Reese are drawing new fans to the sport. This certainly bodes well for companies that have entered WNBA partnerships. According to the
Right now, growth investors are focused primarily on opportunities in the semiconductors and artificial intelligence stocks space. That’s understandable, given how fast technology is advancing in those areas right now. But investors shouldn’t lose sight of other technological developments as well. For example, robotics stocks should enjoy considerable growth in the years to come. Particularly
The AI wars are heating up, and Elon Musk has joined the race. Grok, X’s chatbot, is his answer to OpenAI’s ChatGPT. While Musk has long touted Tesla (NASDAQ:TSLA) as one of the top AI stocks due to its self-driving technology, his attention has turned to Grok. In May, xAI announced a series B round
In 2024, the iShares Biotechnology ETF (NASDAQ:IBB) is up just over 1.5%. If you’re looking for steady, dividend-paying stocks, you can find a number of biotech stocks to buy from the holdings in this fund. However, if you’re looking for the chance to turn a modest investment into, perhaps, generational wealth, the list becomes narrower and